- Home
- Publications
- Publication Search
- Publication Details
Title
Targeting the Microenvironment in High Grade Serous Ovarian Cancer
Authors
Keywords
-
Journal
Cancers
Volume 10, Issue 8, Pages 266
Publisher
MDPI AG
Online
2018-08-10
DOI
10.3390/cancers10080266
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study).
- (2018) Ilary Ruscito et al. BRITISH JOURNAL OF CANCER
- Ovarian cancer-derived extracellular vesicles affect normal human fibroblast behavior
- (2018) Ilaria Giusti et al. CANCER BIOLOGY & THERAPY
- Tissue Tranglutaminase Regulates Interactions between Ovarian Cancer Stem Cells and the Tumor Niche
- (2018) Salvatore Condello et al. CANCER RESEARCH
- Platelet-Derived Growth Factor D Is a Prognostic Biomarker and Is Associated With Platinum Resistance in Epithelial Ovarian Cancer
- (2018) Mengjun Zhang et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation
- (2018) Mana Taki et al. Nature Communications
- miR200-regulated CXCL12β promotes fibroblast heterogeneity and immunosuppression in ovarian cancers
- (2018) Anne-Marie Givel et al. Nature Communications
- Tumor-derived exosomal miR-1247-3p induces cancer-associated fibroblast activation to foster lung metastasis of liver cancer
- (2018) Tian Fang et al. Nature Communications
- Bevacizumab and paclitaxel–carboplatin chemotherapy and secondary cytoreduction in recurrent, platinum-sensitive ovarian cancer (NRG Oncology/Gynecologic Oncology Group study GOG-0213): a multicentre, open-label, randomised, phase 3 trial
- (2017) Robert L Coleman et al. LANCET ONCOLOGY
- Therapeutic Impact of Nanoparticle Therapy Targeting Tumor-Associated Macrophages
- (2017) Courtney A. Penn et al. MOLECULAR CANCER THERAPEUTICS
- A loop of cancer-stroma-cancer interaction promotes peritoneal metastasis of ovarian cancer via TNFα-TGFα-EGFR
- (2017) T-S Lau et al. ONCOGENE
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting TGF-β Signaling for Therapeutic Gain
- (2017) Rosemary J. Akhurst Cold Spring Harbor Perspectives in Biology
- Integrins as Therapeutic Targets: Successes and Cancers
- (2017) Sabine Raab-Westphal et al. Cancers
- Therapeutic strategies for targeting the ovarian tumor stroma
- (2017) Song Yi Ko et al. World Journal of Clinical Cases
- Expression of Vascular Endothelial Growth Factor in Ovarian Cancer Inhibits Tumor Immunity through the Accumulation of Myeloid-Derived Suppressor Cells
- (2016) Naoki Horikawa et al. CLINICAL CANCER RESEARCH
- Systematic evaluation of multiple immune markers reveals prognostic factors in ovarian cancer
- (2016) Phillip P. Santoiemma et al. GYNECOLOGIC ONCOLOGY
- PD-L1 expression is associated with tumor-infiltrating T cells and favorable prognosis in high-grade serous ovarian cancer
- (2016) John R. Webb et al. GYNECOLOGIC ONCOLOGY
- Combined Immunoscore of CD103 and CD3 Identifies Long-Term Survivors in High-Grade Serous Ovarian Cancer
- (2016) Hans-Christian Bösmüller et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Tumor-associated macrophages drive spheroid formation during early transcoelomic metastasis of ovarian cancer
- (2016) Mingzhu Yin et al. JOURNAL OF CLINICAL INVESTIGATION
- Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial
- (2016) Andreas du Bois et al. LANCET ONCOLOGY
- Depletion of FAP+ cells reduces immunosuppressive cells and improves metabolism and functions CD8+T cells within tumors
- (2016) Ying Zhang et al. Oncotarget
- Association and prognostic significance of BRCA1/2-mutation status with neoantigen load, number of tumor-infiltrating lymphocytes and expression of PD-1/PD-L1 in high grade serous ovarian cancer
- (2016) Kyle C. Strickland et al. Oncotarget
- BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression
- (2016) Hengrui Zhu et al. Cell Reports
- Interleukin-6 Stimulates Defective Angiogenesis
- (2015) G. Gopinathan et al. CANCER RESEARCH
- The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in Melanoma
- (2015) Kathleen M. Mahoney et al. CLINICAL THERAPEUTICS
- State of the science: Emerging therapeutic strategies for targeting angiogenesis in ovarian cancer
- (2015) Whitney Graybill et al. GYNECOLOGIC ONCOLOGY
- A phase 2 study of cediranib in recurrent or persistent ovarian, peritoneal or fallopian tube cancer: A trial of the Princess Margaret, Chicago and California Phase II Consortia
- (2015) H. Hirte et al. GYNECOLOGIC ONCOLOGY
- Overall Survival and Long-Term Safety of Nivolumab (Anti–Programmed Death 1 Antibody, BMS-936558, ONO-4538) in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer
- (2015) Scott N. Gettinger et al. JOURNAL OF CLINICAL ONCOLOGY
- Mismatch repair deficiency predicts benefit of anti-PD-1 therapy
- (2015) Esther Lau LANCET ONCOLOGY
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab versus Ipilimumab in Advanced Melanoma
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-tumor activity of the TGF-β receptor kinase inhibitor galunisertib (LY2157299 monohydrate) in patient-derived tumor xenografts
- (2015) Armin Maier et al. CELLULAR ONCOLOGY
- Prognostic impact of programmed cell death-1 (PD-1) and PD-ligand 1 (PD-L1) expression in cancer cells and tumor-infiltrating lymphocytes in ovarian high grade serous carcinoma
- (2015) Silvia Darb-Esfahani et al. Oncotarget
- Extracellular Tissue Transglutaminase Activates Noncanonical NF-κB Signaling and Promotes Metastasis in Ovarian Cancer
- (2015) Bakhtiyor Yakubov et al. NEOPLASIA
- Tumor-induced perturbations of cytokines and immune cell networks
- (2014) Brett Burkholder et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Cardiac Safety of TGF-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Cancer Patients in a First-in-Human Dose Study
- (2014) Richard J. Kovacs et al. Cardiovascular Toxicology
- TGF-beta Signaling in Cancer Treatment
- (2014) Isabel Fabregat et al. CURRENT PHARMACEUTICAL DESIGN
- What have we learned from trials on antiangiogenic agents in glioblastoma?
- (2014) Riccardo Soffietti et al. Expert Review of Neurotherapeutics
- Tumor-Associated Macrophages: From Mechanisms to Therapy
- (2014) Roy Noy et al. IMMUNITY
- Mesenchymal gene program–expressing ovarian cancer spheroids exhibit enhanced mesothelial clearance
- (2014) Rachel A. Davidowitz et al. JOURNAL OF CLINICAL INVESTIGATION
- Mesothelial cells promote early ovarian cancer metastasis through fibronectin secretion
- (2014) Hilary A. Kenny et al. JOURNAL OF CLINICAL INVESTIGATION
- Bevacizumab Combined With Chemotherapy for Platinum-Resistant Recurrent Ovarian Cancer: The AURELIA Open-Label Randomized Phase III Trial
- (2014) Eric Pujade-Lauraine et al. JOURNAL OF CLINICAL ONCOLOGY
- Subsets of Myeloid-Derived Suppressor Cells in Tumor-Bearing Mice
- (2014) J.-I. Youn et al. JOURNAL OF IMMUNOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Small Molecule Inhibitors Target the Tissue Transglutaminase and Fibronectin Interaction
- (2014) Bakhtiyor Yakubov et al. PLoS One
- A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
- (2014) Meiying Zhang et al. Journal of Ovarian Research
- Fibroblasts in fibrosis: novel roles and mediators
- (2014) Ryan T. Kendall et al. Frontiers in Pharmacology
- Expression of the Homeobox Gene HOXA9 in Ovarian Cancer Induces Peritoneal Macrophages to Acquire an M2 Tumor-Promoting Phenotype
- (2013) Song Yi Ko et al. AMERICAN JOURNAL OF PATHOLOGY
- Therapeutic PD-1 Pathway Blockade Augments with Other Modalities of Immunotherapy T-Cell Function to Prevent Immune Decline in Ovarian Cancer
- (2013) J. Duraiswamy et al. CANCER RESEARCH
- CD137 Accurately Identifies and Enriches for Naturally Occurring Tumor-Reactive T Cells in Tumor
- (2013) Q. Ye et al. CLINICAL CANCER RESEARCH
- Fibroblast activation protein-α promotes ovarian cancer cell proliferation and invasion via extracellular and intracellular signaling mechanisms
- (2013) WeiWei Yang et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- Tissue transglutaminase regulates β-catenin signaling through a c-Src-dependent mechanism
- (2013) Salvatore Condello et al. FASEB JOURNAL
- Myeloid-Derived Suppressor Cells Enhance Stemness of Cancer Cells by Inducing MicroRNA101 and Suppressing the Corepressor CtBP2
- (2013) Tracy X. Cui et al. IMMUNITY
- A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
- (2013) Lana E Kandalaft et al. Journal of Translational Medicine
- ‘Cancer associated fibroblasts’ – more than meets the eye
- (2013) Shalom Madar et al. TRENDS IN MOLECULAR MEDICINE
- Matrix metalloproteinases in cancer: their value as diagnostic and prognostic markers and therapeutic targets
- (2013) Elin Hadler-Olsen et al. TUMOR BIOLOGY
- Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
- (2012) Douglas Hanahan et al. CANCER CELL
- Inhibition of focal adhesion kinase (FAK) activity prevents anchorage-independent ovarian carcinoma cell growth and tumor progression
- (2012) Kristy K. Ward et al. CLINICAL & EXPERIMENTAL METASTASIS
- HOXA9 promotes ovarian cancer growth by stimulating cancer-associated fibroblasts
- (2012) Song Yi Ko et al. JOURNAL OF CLINICAL INVESTIGATION
- Dasatinib reverses Cancer-associated Fibroblasts (CAFs) from primary Lung Carcinomas to a Phenotype comparable to that of normal Fibroblasts
- (2012) Silke Haubeiss et al. Molecular Cancer
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Colorectal Cancer Cells Activate Adjacent Fibroblasts Resulting in FGF1/FGFR3 Signaling and Increased Invasion
- (2011) Maria L. Henriksson et al. AMERICAN JOURNAL OF PATHOLOGY
- Fibroblasts in omentum activated by tumor cells promote ovarian cancer growth, adhesion and invasiveness
- (2011) J. Cai et al. CARCINOGENESIS
- MMP-2 functions as an early response protein in ovarian cancer metastasis
- (2011) Hilary A. Kenny et al. CELL CYCLE
- A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer
- (2011) Katherine M. Bell-McGuinn et al. GYNECOLOGIC ONCOLOGY
- A phase II study of aflibercept in patients with advanced epithelial ovarian cancer and symptomatic malignant ascites
- (2011) Nicoletta Colombo et al. GYNECOLOGIC ONCOLOGY
- The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer
- (2011) Shogo Yamamura et al. INTERNATIONAL JOURNAL OF CANCER
- Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer
- (2011) Jonathan A. Ledermann et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Infiltrating Programmed Death Receptor-1+ Dendritic Cells Mediate Immune Suppression in Ovarian Cancer
- (2011) J. Krempski et al. JOURNAL OF IMMUNOLOGY
- Targeting Ovarian Tumor Cell Adhesion Mediated by Tissue Transglutaminase
- (2011) M. Khanna et al. MOLECULAR CANCER THERAPEUTICS
- Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
- (2011) Kristin M Nieman et al. NATURE MEDICINE
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Ovarian Cancer Spheroids Use Myosin-Generated Force to Clear the Mesothelium
- (2011) Marcin P. Iwanicki et al. Cancer Discovery
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- Immunotherapy targeting fibroblast activation protein inhibits tumor growth and increases survival in a murine colon cancer model
- (2010) Yuan Wen et al. CANCER SCIENCE
- Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group Trial
- (2010) Daniela Matei et al. JOURNAL OF CLINICAL ONCOLOGY
- Clinical Applications of VEGF-Trap (Aflibercept) in Cancer Treatment
- (2010) Li-Song Teng et al. Journal of the Chinese Medical Association
- Ligand-independent activation of c-Met by fibronectin and α5β1-integrin regulates ovarian cancer invasion and metastasis
- (2010) A K Mitra et al. ONCOGENE
- Suppression of Antitumor Immunity by Stromal Cells Expressing Fibroblast Activation Protein-
- (2010) M. Kraman et al. SCIENCE
- β 3 -Integrin Expression on Tumor Cells Inhibits Tumor Progression, Reduces Metastasis, and Is Associated with a Favorable Prognosis in Patients with Ovarian Cancer
- (2009) Swayamjot Kaur et al. AMERICAN JOURNAL OF PATHOLOGY
- Vascular Cell Adhesion Molecule-1 Is a Regulator of Ovarian Cancer Peritoneal Metastasis
- (2009) Jill K. Slack-Davis et al. CANCER RESEARCH
- Epithelial-to-Mesenchymal Transition and Ovarian Tumor Progression Induced by Tissue Transglutaminase
- (2009) M. Shao et al. CANCER RESEARCH
- MMP13 as a stromal mediator in controlling persistent angiogenesis in skin carcinoma
- (2009) Wiltrud Lederle et al. CARCINOGENESIS
- Aflibercept in epithelial ovarian carcinoma
- (2009) John W Moroney et al. Future Oncology
- Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity
- (2009) Minati Satpathy et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer
- (2009) Ursula A. Matulonis et al. JOURNAL OF CLINICAL ONCOLOGY
- Identifying alemtuzumab as an anti-myeloid cell antiangiogenic therapy for the treatment of ovarian cancer
- (2009) Heather L Pulaski et al. Journal of Translational Medicine
- Cancer Associated Fibroblasts Promote Tumor Growth and Metastasis by Modulating the Tumor Immune Microenvironment in a 4T1 Murine Breast Cancer Model
- (2009) Debbie Liao et al. PLoS One
- Imatinib mesylate in combination with docetaxel for the treatment of patients with advanced, platinum-resistant ovarian cancer and primary peritoneal carcinomatosis
- (2008) Daniela Matei et al. CANCER
- Loss of E-Cadherin Promotes Ovarian Cancer Metastasis via 5-Integrin, which Is a Therapeutic Target
- (2008) K. Sawada et al. CANCER RESEARCH
- Vascular Endothelial Growth Factor Expression in Ovarian Cancer: A Model for Targeted Use of Novel Therapies?
- (2008) T. J. Duncan et al. CLINICAL CANCER RESEARCH
- Maintenance Treatment with Bevacizumab Prolongs Survival in an In vivo Ovarian Cancer Model
- (2008) S. Mabuchi et al. CLINICAL CANCER RESEARCH
- CXCL8/IL-8 and CXCL12/SDF-1α co-operatively promote invasiveness and angiogenesis in pancreatic cancer
- (2008) Yoichi Matsuo et al. INTERNATIONAL JOURNAL OF CANCER
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
- Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting
- (2008) Kristian Pietras et al. PLOS MEDICINE
- Cancer-Derived Lysophosphatidic Acid Stimulates Differentiation of Human Mesenchymal Stem Cells to Myofibroblast-Like Cells
- (2007) Eun Su Jeon et al. STEM CELLS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started